The Polatuzumab Biosimilar Anti-CD79b Antibody offered by Assay Genie is a high-quality research tool designed for the study of CD79b, a key protein involved in B-cell signaling and function. This antibody, produced through biosimilar technology, has been rigorously validated for use in various experimental techniques, including Western blot, immunohistochemistry, and flow cytometry.CD79b is a critical component of the B-cell receptor complex, playing a vital role in B-cell activation and proliferation. Dysregulation of CD79b expression has been implicated in various B-cell malignancies, making it a promising target for cancer research and therapy development. The Polatuzumab Biosimilar Anti-CD79b Antibody provides researchers with a sensitive and specific tool for detecting and measuring CD79b expression in both normal and diseased tissues, enabling deeper insights into the role of this protein in health and disease.
Whether investigating the mechanisms of B-cell signaling, studying the pathogenesis of B-cell lymphomas, or developing novel therapeutic strategies, the Polatuzumab Biosimilar Anti-CD79b Antibody from Assay Genie is a valuable resource for researchers in the fields of immunology, oncology, and beyond. Trust in this antibody to deliver accurate and reliable results, advancing your research towards new discoveries and breakthroughs.
Product Name:
Polatuzumab (Anti-CD79b) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0153
Target:
CD79B
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
RO5541077?RG-7596
Description:
Anti-CD79b(polatuzumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
